Anna Dmoszynska, Janusz Kloczko, Malgorzata Rokicka, Andrzej Hellmann, Ivan Spicka, Joseph E. Eid. A dose exploration, phase I/II study of administration of continuous erythropoietin receptor activator once every 3 weeks in anemic patients with multiple myeloma receiving chemotherapy. haematol [Internet]. 2007Apr.1 [cited 2024Apr.27];92(4):493-01. Available from: https://haematologica.org/article/view/4401